Comparing usability of NEXThaler(®) with other inhaled corticosteroid/long-acting β2-agonist fixed combination dry powder inhalers in asthma patients.
about
Patients' perspectives and preferences in the choice of inhalers: the case for Respimat(®) or HandiHaler(®)Impact of extrafine formulations of inhaled corticosteroids/long-acting beta-2 agonist combinations on patient-related outcomes in asthma and COPD.Advances in device and formulation technologies for pulmonary drug delivery.Assessment of satisfaction with different dry powder inhalation devices in Greek patients with COPD and asthma: the ANASA study.A randomised open-label cross-over study of inhaler errors, preference and time to achieve correct inhaler use in patients with COPD or asthma: comparison of ELLIPTA with other inhaler devices.Inhaled beclometasone dipropionate/formoterol fumarate extrafine fixed combination for the treatment of asthma.Routine Use of Budesonide/Formoterol Fixed Dose Combination in Elderly Asthmatic Patients: Practical Considerations.Effect of Flow Rate on In Vitro Aerodynamic Performance of NEXThaler(®) in Comparison with Diskus(®) and Turbohaler(®) Dry Powder Inhalers.Critical inhaler errors in asthma and COPD: a systematic review of impact on health outcomes.Fluticasone furoate/Vilanterol 92/22 μg once-a-day vs Beclomethasone dipropionate/Formoterol 100/6 μg b.I.D.: a 12-month comparison of outcomes in mild-to-moderate asthma.Fluticasone furoate/vilanterol 92/22 µg once a day: a 12-month study on outcomes in mild to moderate asthma
P2860
Q26738366-8CF50C05-89EB-460F-98A9-EC2CF44CDAD1Q26826860-9883BCE8-5B37-4E5D-8290-A63F75E180C5Q33962567-11B08B8D-FB3C-4804-B2C9-0C2020D8A3D8Q37167808-FC06F98C-E95B-4B1F-B3DC-E31B3143ADECQ37437109-E60DC5C9-9F9D-4F66-B3D5-BAD37104DD73Q38759118-5859B115-EBB8-447B-A22E-D80FC6DB5196Q38930261-CAC9D0CC-96A2-4170-B432-6AC9D5BE2587Q40526870-5C69780D-0CA5-438D-9931-AE621C20F545Q49408972-9C563F4F-5D49-46C4-92A3-959FF9F7E565Q55317003-5F8DA855-DCE7-445F-8C4D-F49176CEE4F3Q58740151-262DAC10-92CE-4D7D-86AD-0EC670721548
P2860
Comparing usability of NEXThaler(®) with other inhaled corticosteroid/long-acting β2-agonist fixed combination dry powder inhalers in asthma patients.
description
2013 nî lūn-bûn
@nan
2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Comparing usability of NEXThal ...... r inhalers in asthma patients.
@ast
Comparing usability of NEXThal ...... r inhalers in asthma patients.
@en
type
label
Comparing usability of NEXThal ...... r inhalers in asthma patients.
@ast
Comparing usability of NEXThal ...... r inhalers in asthma patients.
@en
prefLabel
Comparing usability of NEXThal ...... r inhalers in asthma patients.
@ast
Comparing usability of NEXThal ...... r inhalers in asthma patients.
@en
P2093
P2860
P356
P1476
Comparing usability of NEXThal ...... r inhalers in asthma patients.
@en
P2093
Alice Campanini
Andrea S Melani
Anthony Lafratta
Barbara Ronca
Daniel Lock
Mario Scuri
Monica Spinola
Patrick Linnane
Thomas Voshaar
P2860
P304
P356
10.1089/JAMP.2013.1086
P577
2013-12-03T00:00:00Z